Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Retroperitoneal fibrosis].

S Burkhardt Soares1, S Kukuk, A S Brandt

  • 1Klinik für Urologie und Kinderurologie, HELIOS Klinikum Wuppertal, Universitätsklinikum der Universität Witten/Herdecke, Heusnerstrasse 40, 42283 Wuppertal, Deutschland. sonja.burkhardt-soares@helios-kliniken.de

Der Urologe. Ausg. A
|March 28, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for New Phenomena in Final States with Two Leptons and One or No b-Tagged Jets at sqrt[s]=13  TeV Using the ATLAS Detector.

Physical review letters·2021
Same author

Search for Displaced Leptons in sqrt[s]=13  TeV pp Collisions with the ATLAS Detector.

Physical review letters·2021
Same author

Longitudinal Flow Decorrelations in Xe+Xe Collisions at sqrt[s_{NN}]=5.44  TeV with the ATLAS Detector.

Physical review letters·2021
Same author

Search for Dark Matter Produced in Association with a Dark Higgs Boson Decaying into W^{±}W^{∓} or ZZ in Fully Hadronic Final States from sqrt[s]=13  TeV pp Collisions Recorded with the ATLAS Detector.

Physical review letters·2021
Same author

Medium-Induced Modification of Z-Tagged Charged Particle Yields in Pb+Pb Collisions at 5.02 TeV with the ATLAS Detector.

Physical review letters·2021
Same author

Observation and Measurement of Forward Proton Scattering in Association with Lepton Pairs Produced via the Photon Fusion Mechanism at ATLAS.

Physical review letters·2021
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
See all related articles

Retroperitoneal Fibrosis (RPF) is a rare, possibly autoimmune condition affecting middle-aged adults. Diagnosis involves imaging and biopsy, with treatment including medication or surgery, requiring lifelong monitoring due to potential recurrence.

Area of Science:

  • Nephrology
  • Immunology
  • Rare Diseases

Context:

  • Retroperitoneal Fibrosis (RPF) is a rare condition with unclear etiology, often suggesting autoimmune involvement.
  • It affects individuals typically between their fifth and seventh decades of life.
  • RPF presents with varied symptoms, from general malaise to organ compression.

Purpose:

  • To outline the characteristics, diagnosis, and management of Retroperitoneal Fibrosis.
  • To differentiate between primary/idiopathic and secondary forms of RPF.
  • To emphasize the chronic and relapsing nature of the disease.

Summary:

  • Diagnosis of RPF combines patient history, lab tests, imaging, and often biopsy.
  • Treatment strategies include prednisone, immunosuppressants, or tamoxifen to stabilize the condition.

Related Experiment Videos

  • Ureteral surgery may be necessary for refractory cases, and lifelong follow-up is crucial.

    • Impact:

    • Improved understanding of RPF etiology and diagnostic pathways.
    • Guidance on therapeutic interventions and the necessity of long-term patient management.
    • Highlights the chronic relapsing course of RPF, informing clinical practice and patient care.